These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Delivery of nucleic acid based genome editing platforms via lipid nanoparticles: Clinical applications. Masarwy R; Stotsky-Oterin L; Elisha A; Hazan-Halevy I; Peer D Adv Drug Deliv Rev; 2024 Aug; 211():115359. PubMed ID: 38857763 [TBL] [Abstract][Full Text] [Related]
10. A magnetic separation method for isolating and characterizing the biomolecular corona of lipid nanoparticles. Francia V; Zhang Y; Cheng MHY; Schiffelers RM; Witzigmann D; Cullis PR Proc Natl Acad Sci U S A; 2024 Mar; 121(11):e2307803120. PubMed ID: 38437542 [TBL] [Abstract][Full Text] [Related]
11. The interplay of quaternary ammonium lipid structure and protein corona on lung-specific mRNA delivery by selective organ targeting (SORT) nanoparticles. Dilliard SA; Sun Y; Brown MO; Sung YC; Chatterjee S; Farbiak L; Vaidya A; Lian X; Wang X; Lemoff A; Siegwart DJ J Control Release; 2023 Sep; 361():361-372. PubMed ID: 37536547 [TBL] [Abstract][Full Text] [Related]
12. Evaluating the breadth of nucleic acid-based payloads delivered in lipid nanoparticles to establish fundamental differences in development. Li J; Foged C Expert Opin Drug Deliv; 2024 Oct; 21(10):1441-1461. PubMed ID: 39387233 [TBL] [Abstract][Full Text] [Related]
13. Lipid Nanoparticles Optimized for Targeting and Release of Nucleic Acid. Jia Y; Wang X; Li L; Li F; Zhang J; Liang XJ Adv Mater; 2024 Jan; 36(4):e2305300. PubMed ID: 37547955 [TBL] [Abstract][Full Text] [Related]
14. Lipid Nanoparticles Enabling Gene Therapies: From Concepts to Clinical Utility. Kulkarni JA; Cullis PR; van der Meel R Nucleic Acid Ther; 2018 Jun; 28(3):146-157. PubMed ID: 29683383 [TBL] [Abstract][Full Text] [Related]
15. Lipid nanoparticles for short interfering RNA delivery. Leung AK; Tam YY; Cullis PR Adv Genet; 2014; 88():71-110. PubMed ID: 25409604 [TBL] [Abstract][Full Text] [Related]
16. Development of Lipid Nanoparticles for the Delivery of Macromolecules Based on the Molecular Design of pH-Sensitive Cationic Lipids. Sato Y Chem Pharm Bull (Tokyo); 2021; 69(12):1141-1159. PubMed ID: 34853281 [TBL] [Abstract][Full Text] [Related]
18. In utero delivery of targeted ionizable lipid nanoparticles facilitates in vivo gene editing of hematopoietic stem cells. Palanki R; Riley JS; Bose SK; Luks V; Dave A; Kus N; White BM; Ricciardi AS; Swingle KL; Xue L; Sung D; Thatte AS; Safford HC; Chaluvadi VS; Carpenter M; Han EL; Maganti R; Hamilton AG; Mrksich K; Billingsley MB; Zoltick PW; Alameh MG; Weissman D; Mitchell MJ; Peranteau WH Proc Natl Acad Sci U S A; 2024 Aug; 121(32):e2400783121. PubMed ID: 39078677 [TBL] [Abstract][Full Text] [Related]
19. Lipid nanoparticle (LNP) mediated mRNA delivery in cardiovascular diseases: Advances in genome editing and CAR T cell therapy. Soroudi S; Jaafari MR; Arabi L J Control Release; 2024 Aug; 372():113-140. PubMed ID: 38876358 [TBL] [Abstract][Full Text] [Related]
20. A tale of nucleic acid-ionizable lipid nanoparticles: Design and manufacturing technology and advancement. De A; Ko YT Expert Opin Drug Deliv; 2023 Jan; 20(1):75-91. PubMed ID: 36445261 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]